FI762053A - - Google Patents

Info

Publication number
FI762053A
FI762053A FI762053A FI762053A FI762053A FI 762053 A FI762053 A FI 762053A FI 762053 A FI762053 A FI 762053A FI 762053 A FI762053 A FI 762053A FI 762053 A FI762053 A FI 762053A
Authority
FI
Finland
Application number
FI762053A
Other languages
Finnish (fi)
Inventor
George Madison Sieger
James Elwood Krueger
Arnold Curtis Osterberg
David Henry Tedeschi
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI762053A publication Critical patent/FI762053A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI762053A 1975-07-16 1976-07-15 FI762053A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/596,488 US4016273A (en) 1975-07-16 1975-07-16 Sustained release forms of certain oxazepines for parenteral administration

Publications (1)

Publication Number Publication Date
FI762053A true FI762053A (en) 1977-01-17

Family

ID=24387483

Family Applications (1)

Application Number Title Priority Date Filing Date
FI762053A FI762053A (en) 1975-07-16 1976-07-15

Country Status (11)

Country Link
US (1) US4016273A (en)
BE (1) BE844203A (en)
CA (1) CA1062159A (en)
DE (1) DE2630394A1 (en)
DK (1) DK319776A (en)
FI (1) FI762053A (en)
FR (1) FR2317912A1 (en)
GB (1) GB1525425A (en)
NL (1) NL7607918A (en)
PT (1) PT65358B (en)
SE (1) SE7608114L (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US6199634B1 (en) 1998-08-27 2001-03-13 Viatchelav Ivanovich Selyakov Method and apparatus for controlling the permeability of mineral bearing earth formations
CA2406790C (en) * 2000-04-19 2009-07-07 Genentech, Inc. Sustained release formulations
WO2002013870A2 (en) * 2000-08-17 2002-02-21 Mitokor, Inc. Formulation for administering therapeutic lipophilic molecules
DE10059020A1 (en) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Dosage forms that can be administered parenterally
ES2554106T3 (en) * 2001-06-21 2015-12-16 Genentech, Inc. Sustained Release Formulation
CN1827766B (en) * 2001-06-28 2010-08-25 徐荣祥 In vitro cell cultivation method
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
US6972195B2 (en) * 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
RU2006128593A (en) * 2004-01-07 2008-02-20 Тримерис, Инк. (Us) SYNTHETIC PEPTIDES, Derivatives of the HR2 PROTEIN GP41 HIV, AND THEIR APPLICATION IN THERAPY FOR INHIBITING THE PERMISSION OF HUMAN IMMUNODEFICIENCY VIRUS
US7932249B2 (en) * 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
NZ570300A (en) * 2006-02-02 2011-08-26 Trimeris Inc HIV fusion inhibitor peptides with improved biological properties
ES2346005T3 (en) * 2006-07-27 2010-10-07 Cognis Ip Management Gmbh PROCEDURE FOR OBTAINING GLYCERINE.
EP2139526A4 (en) * 2007-04-03 2010-07-14 Trimeris Inc Novel formulations for delivery of antiviral peptide therapeutics
KR20100080812A (en) * 2007-09-25 2010-07-12 트라이머리스, 인코퍼레이티드 Methods of synthesis for therapeuthic anti-hiv peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3164520A (en) * 1962-10-29 1965-01-05 Olin Mathieson Injectable steroid compositions containing at least 75% benzyl benzoate
NL140242B (en) * 1963-03-01 1973-11-15 Wander Ag Dr A METHOD FOR PREPARING THE 11-PLACE SUBSTITUTED DIBENZ (B.F.) (1.4) OXAZEPINES BY A BASIC GROUP.
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3546220A (en) * 1966-08-01 1970-12-08 Abbott Lab 2,3-dihydro-1h-pyrido-(2,3-b)(1,4)thiazines
US3549621A (en) * 1968-04-29 1970-12-22 Harry Louis Yale 12-substituted-6h-dibenz(b,f)(1,4)oxazocin-11(12h) ones
US3891647A (en) * 1970-08-06 1975-06-24 Wander Ag Dr A 2-trifluoromethyl-sulphonyl-11-substituted-piperazinyl-dibenz {8 b,f{9 {8 1,4{9 {0 oxazepine
US3773768A (en) * 1970-10-26 1973-11-20 American Cyanamid Co 7-amino-2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine and salts thereof

Also Published As

Publication number Publication date
DE2630394A1 (en) 1977-02-03
CA1062159A (en) 1979-09-11
FR2317912A1 (en) 1977-02-11
FR2317912B1 (en) 1979-04-13
NL7607918A (en) 1977-01-18
GB1525425A (en) 1978-09-20
PT65358A (en) 1976-08-01
SE7608114L (en) 1977-01-17
DK319776A (en) 1977-01-17
PT65358B (en) 1978-01-09
BE844203A (en) 1977-01-17
US4016273A (en) 1977-04-05

Similar Documents

Publication Publication Date Title
FR2302404B1 (en)
FR2317912B1 (en)
FR2317737B1 (en)
JPS5192402U (en)
JPS5189886U (en)
JPS5225769U (en)
JPS5217640U (en)
JPS51110234U (en)
JPS5242044U (en)
JPS5267317U (en)
JPS5276681U (en)
JPS51126215U (en)
CH603240A5 (en)
CH599590B5 (en)
CH610393A5 (en)
CH607112A5 (en)
CH606924A5 (en)
CH606763A5 (en)
CH605493A5 (en)
CH604484A5 (en)
CH604482A5 (en)
CH604443A5 (en)
CH604382A5 (en)
CH595435A5 (en)
CH595058A5 (en)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: AMERICAN CYANAMID COMPANY